v3.26.1
Debt - Schedule of Collateralized Loan Obligations (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Dec. 31, 2024
Assets        
Cash and cash equivalents $ 115,600 $ 167,292 $ 215,368 $ 184,443
Total commercial mortgage loans, held for investment, net [1] 4,546,828 4,383,134    
Accrued interest receivable 38,942 41,468    
Total assets 6,301,001 6,057,250    
Liabilities        
Notes payable 23,998 23,998    
Accrued interest payable 16,751 16,110    
Total liabilities 4,731,207 4,436,025    
Allowance for credit loss [1] 49,173 38,302    
U.S. Bank National Association | Secured debt        
Liabilities        
Notes payable 3,510,608 3,510,608    
Collaterized loan obligation        
Assets        
Cash and cash equivalents 79,775 51,153    
Total commercial mortgage loans, held for investment, net 3,192,044 3,317,040    
Accrued interest receivable 16,045 18,302    
Total assets 3,287,864 3,386,495    
Liabilities        
Notes payable 3,023,291 3,123,046    
Accrued interest payable 8,085 8,857    
Total liabilities 3,031,376 3,131,903    
Restricted cash 79,100 50,500    
Allowance for credit loss 13,100 15,400    
Deferred financing cost and discount 19,800 21,300    
Collaterized loan obligation | U.S. Bank National Association | Secured debt        
Liabilities        
Collateralized loan obligation excluded $ 366,100 $ 366,100    
[1] Includes pledged assets of $409.4 million and $329.2 million as of March 31, 2026 and December 31, 2025, respectively.